SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739614-20-000014
Filing Date
2020-11-13
Accepted
2020-11-13 16:09:24
Documents
73
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inhibrx-20200930.htm   iXBRL 10-Q 2029959
2 EX-10.11 exhibit1011-firstamend.htm EX-10.11 85460
3 EX-31.1 exhibit311.htm EX-31.1 9491
4 EX-31.2 exhibit312.htm EX-31.2 9501
5 EX-32.1 exhibit321.htm EX-32.1 5092
6 EX-32.2 exhibit322.htm EX-32.2 5089
  Complete submission text file 0001739614-20-000014.txt   8791205

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20200930.xsd EX-101.SCH 58905
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inhibrx-20200930_cal.xml EX-101.CAL 86576
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inhibrx-20200930_def.xml EX-101.DEF 346641
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20200930_lab.xml EX-101.LAB 683485
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20200930_pre.xml EX-101.PRE 522460
12 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20200930_htm.xml XML 1285049
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39452 | Film No.: 201311564
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences